Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EBT (2020 - 2025)

LifeStance Health (LFST) has disclosed EBT for 6 consecutive years, with $15.2 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 271.28% to $15.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.4 million, a 121.46% increase, with the full-year FY2025 number at $12.4 million, up 121.46% from a year prior.
  • EBT was $15.2 million for Q4 2025 at LifeStance Health, up from $4.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $15.2 million in Q4 2025 to a low of -$128.2 million in Q3 2021.
  • A 5-year average of -$40.7 million and a median of -$38.3 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 1171.54% in 2021, then skyrocketed 271.28% in 2025.
  • LifeStance Health's EBT stood at -$118.6 million in 2021, then skyrocketed by 54.72% to -$53.7 million in 2022, then rose by 28.67% to -$38.3 million in 2023, then soared by 76.83% to -$8.9 million in 2024, then surged by 271.28% to $15.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's EBT are $15.2 million (Q4 2025), $4.6 million (Q3 2025), and -$5.9 million (Q2 2025).